Menu
Search
|

Menu

Close
X

Beijing Tiantan Biological Products Corp Ltd 600161.SS (Shanghai Stock Exchange)

25.64 CNY
+0.02 (+0.08%)
As of Feb 23
chart
Previous Close 25.62
Open 25.56
Volume 2,630,829
3m Avg Volume 7,210,755
Today’s High 25.75
Today’s Low 25.43
52 Week High 39.60
52 Week Low 23.85
Shares Outstanding (mil) 670.11
Market Capitalization (mil) 22,026.41
Forward P/E 19.84
Dividend (Yield %) 0.23 ( 0.70 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

No Data Available
Sell Hold Buy

KEY STATS

Revenue (mm, CNY)
FY17
944
FY16
2,130
FY15
1,618
EPS (CNY)
FY17
1.411
FY16
0.440
FY15
0.015
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
19.84
32.90
Price to Sales (TTM)
vs sector
10.20
5.77
Price to Book (MRQ)
vs sector
7.85
5.41
Price to Cash Flow (TTM)
vs sector
--
23.42
Total Debt to Equity (MRQ)
vs sector
7.13
16.52
LT Debt to Equity (MRQ)
vs sector
7.13
12.22
Return on Investment (TTM)
vs sector
32.86
14.43
Return on Equity (TTM)
vs sector
45.83
16.13

EXECUTIVE LEADERSHIP

Xiaoming Yang
Chairman of the Board, Since 2010
Salary: --
Bonus: --
Yi Zhang
Chief Financial Officer, Deputy General Manager, Since 2017
Salary: --
Bonus: --
Daoxing Fu
General Manager, Since 2017
Salary: --
Bonus: --
Bainian Fu
Deputy General Manager, Since 2012
Salary: --
Bonus: --
Hongji Xu
Deputy General Manager, Since 2011
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

No. 4
Sanjianfang Nanli, Chaoyang Dist
BEIJING   BEJ   100176

Phone: +8610.60963010

BEIJING TIANTAN BIOLOGICAL PRODUCTS CORPORATION LIMITED is a China-based company principally engaged in the biopharmaceutical businesses. The Company’s primary products include preventive products, blood products and other biological products, such as the influenza A (H1N1) vaccines (split, inactivated),hepatitis B vaccines, poliomyelitis vaccines, measles-mump-rubella (MMR) vaccines, encephalitis B vaccines, influenza vaccinations, bacterial vaccines, human serum albumin (HSA) and intravenous immunoglobulin (IVIG), among others. The Company mainly distributes its products within domestic markets and to Hong Kong markets.

SPONSORED STORIES